Understanding the effects of vaping control policies on youth and adults
Assessing the impact of vaping control policies at the school, local and state levels
['FUNDING_R01'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-10898751
This study looks at how rules about vaping, like age limits and flavor bans, affect how much young people and adults use e-cigarettes, and it aims to find out if these rules help lower vaping rates and keep non-users safe, while also considering how e-cigarettes might help some people quit smoking.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10898751 on ClinicalTrials.gov |
What this research studies
This research investigates how different vaping control policies, such as age restrictions and flavor bans, impact the use of electronic nicotine delivery systems (ENDS) among youth and adults. By analyzing publicly available data, the study aims to assess the effectiveness of these policies in reducing vaping rates and protecting non-users from exposure. The research also explores the potential benefits of ENDS as smoking cessation aids under certain conditions. Overall, it seeks to provide insights into the broader implications of vaping regulations on public health.
Who could benefit from this research
Good fit: Ideal candidates for this research include youth and young adults under 21 who are current or former users of vaping products.
Not a fit: Patients who do not use vaping products or are over the age of 21 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaping regulations that reduce youth vaping and improve public health outcomes.
How similar studies have performed: Previous research has shown that similar regulatory approaches can effectively reduce tobacco use among youth, suggesting potential success for this study's methods.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEVY, DOUGLAS — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: LEVY, DOUGLAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.